Rani Therapeutics Holdings (RANI) Cash from Investing Activities (2020 - 2026)

Rani Therapeutics Holdings' Cash from Investing Activities history spans 7 years, with the latest figure at -$2.4 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 113.44% to -$2.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$27.7 million, a 199.87% decrease, with the full-year FY2025 number at -$7.0 million, down 135.49% from a year prior.
  • Cash from Investing Activities came in at -$2.4 million for Q1 2026, up from -$31.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $18.2 million in Q1 2025, with the low at -$71.3 million in Q3 2022.
  • Historically, Cash from Investing Activities has averaged -$2.0 million across 5 years, with a median of $1.7 million in 2023.
  • Biggest five-year swings in Cash from Investing Activities: soared 3004.6% in 2023 and later tumbled 1328.56% in 2025.
  • Year by year, Cash from Investing Activities stood at -$457000.0 in 2022, then surged by 3004.6% to $13.3 million in 2023, then crashed by 81.01% to $2.5 million in 2024, then plummeted by 1328.56% to -$31.0 million in 2025, then skyrocketed by 92.09% to -$2.4 million in 2026.
  • Business Quant data shows Cash from Investing Activities for RANI at -$2.4 million in Q1 2026, -$31.0 million in Q4 2025, and $5.7 million in Q2 2025.